This is an amended filing · View original →
GeneOne Life Science, Inc. Q1 revenue KRW 2.6 billion, operating loss of KRW 2.3 billion
AI summary · Not investment advice
In Q1, the company sold KRW 2.6 billion worth and lost KRW 2.3 billion from its main business, versus sales of KRW 8.5 billion and a loss of KRW 9.1 billion a year earlier.
Operating profit · 3 months
KRW -2.3 billion
Key facts
- Revenue (3 months)
- KRW 2.6 billion
- Net income (3 months)
- KRW -2.4 billion
- Period
- Q1 (2026.01.01 ~ 2026.03.31)
- Revenue (prior-year 3 months)
- KRW 8.5 billion
- Operating profit (prior-year 3 months)
- KRW -9.1 billion
- Net income (prior-year 3 months)
- KRW -8.8 billion
Commentary
AI commentary · Not investment advice
What happened
GeneOne Life Science reported its consolidated results for the first quarter of 2026, covering January to March. Sales for the three months were KRW 2.58 billion. That is -69.6% from KRW 8.50 billion in the same period a year earlier.
In the company's terms
Operating profit (money earned from the core business) was KRW -2.34 billion for the three months. A year earlier it was KRW -9.07 billion. Net income (the final amount left after all costs and taxes) was KRW -2.38 billion. A year earlier it was KRW -8.84 billion.
Earlier Periodic Report filings from this company
| Filed | Title | Key figure · Note |
|---|---|---|
| 26.11.162026.11.16 | Periodic Report | KRW -5.4 billion |
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
G